Nisa Investment Advisors’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9K Buy
126
+22
+21% +$2.2K ﹤0.01% 2414
2026
Q1
$6.99K Hold
104
﹤0.01% 2362
2025
Q4
$8.22K Buy
104
+93
+845% +$6.34K ﹤0.01% 2307
2025
Q3
$370 Hold
11
﹤0.01% 2891
2025
Q2
$157 Sell
11
-63
-85% -$814 ﹤0.01% 3017
2025
Q1
$1.03K Sell
74
-494
-87% -$6.71K ﹤0.01% 2629
2024
Q4
$8.75K Buy
568
+57
+11% +$868 ﹤0.01% 2163
2024
Q3
$8K Buy
511
+261
+104% +$3.67K ﹤0.01% 2135
2024
Q2
$3.54K Buy
+250
New +$3.9K ﹤0.01% 2308

Other funds holding INBX

Nisa Investment Advisors's INBX Position: Q2 2026 in Review

Nisa Investment Advisors increased its Inhibrx (INBX) stake by 21% in Q2 2026, buying an estimated $2.2K and bringing the position to 126 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2414.

Nisa Investment Advisors first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 49 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Nisa Investment Advisors held 126 shares of Inhibrx worth $11.9K as of Q2 2026.
  • Nisa Investment Advisors bought 22 Inhibrx shares in Q2 2026, an estimated $2.2K.
  • Inhibrx made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2414 holding.
  • Nisa Investment Advisors first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 49 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.